Birth Day | May 25, 1926 |
Birth Place | Germany |
Age | 94 YEARS OLD |
Died On | 13 October 2016(2016-10-13) (aged 90) |
Birth Sign | Gemini |
Residence | Gstaad, Switzerland |
Alma mater | University of Texas at Austin |
Known for | Former owner, Boehringer Mannheim and DePuy Inc. |
Children | 5 |
Relatives | Friedrich Engelhorn (great-grandfather) |
Curt Engelhorn & family, a prominent name associated with the healthcare sector in Germany, holds an estimated net worth of $6.2 billion as of 2024. With a long-standing history of contributions in the healthcare industry, the Engelhorn family has solidified their position as successful entrepreneurs in Germany. Their substantial wealth is a result of their investments and involvement in various healthcare ventures, showcasing their deep understanding and commitment to this crucial sector. With their vast fortune, the Engelhorn family continues to create a positive impact on healthcare and further solidifies their role as trusted contributors to the well-being of the nation.
For more than three and a half decades, Engelhorn led the pharmaceutical companies Boehringer Mannheim and DePuy Inc. In 1997 he sold the two firms (in which together he had a 40% stake) to Hoffmann-La Roche for more than $10 billion.
Since late 2013, there have been ongoing investigations by the German authorities concerning suspected tax frauds between Engelhorn and his daughters, avoiding capital transfer taxes of up to Euro 440 million (US$475 million). As of January 2016, the family's lawyers conceded capital transfer tax evasions in the amount of Euro 135 million (US $145 million) to the court.
As of June 2015, according to Forbes, Engelhorn had a net worth of $6.2 billion. He died on 13 October 2016, aged 90.